GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Precision System Science Co 7707.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

189

+3.85%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥5.22bn

FY2017FY2026

Net income

¥394.9m

FY2017FY2026

Free cash flow

−¥50.6m

FY2017FY2026

Shareholders' equity

¥4.09bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥5.22bn¥4.69bn¥3.98bn¥5.28bn¥7.43bn¥9.30bn¥5.07bn¥4.38bn¥3.64bn¥3.85bn
Gross profit¥1.58bn¥1.38bn¥950.4m¥1.35bn¥2.49bn¥3.10bn¥1.56bn¥1.55bn¥1.31bn¥1.35bn
Research and development—¥128.9m¥216.0m¥375.0m¥385.0m¥551.0m¥522.0m¥377.0m¥568.1m¥647.0m
Operating income¥201.3m−¥121.5m−¥956.2m−¥1.11bn¥205.6m¥895.3m−¥82.4m¥164.0m−¥429.5m−¥566.0m
Net income¥394.9m−¥253.1m−¥1.12bn−¥1.32bn¥45.3m¥796.0m−¥114.3m¥130.3m−¥457.6m−¥555.2m
Diluted earnings per share14.41-9.22-40.59-47.931.6428.81-4.335.20-19.82-24.07

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥5.85bn¥4.94bn¥6.40bn¥9.76bn¥11.41bn¥11.57bn¥6.44bn¥5.50bn¥5.13bn¥5.80bn
Cash and short-term investments¥1.37bn¥1.04bn¥1.92bn¥2.45bn¥2.76bn¥4.04bn¥2.11bn¥1.85bn¥2.06bn¥2.44bn
Total liabilities¥1.76bn¥1.18bn¥2.25bn¥4.54bn¥4.90bn¥4.99bn¥2.12bn¥1.53bn¥1.84bn¥2.05bn
Debt¥1.03bn¥564.2m¥1.37bn¥3.88bn¥4.02bn¥3.69bn¥1.01bn¥963.9m¥1.22bn¥1.46bn
Shareholders' equity¥4.09bn¥3.76bn¥4.14bn¥5.22bn¥6.51bn¥6.58bn¥4.32bn¥3.98bn¥3.29bn¥3.75bn
Shares outstanding27m27m28m28m28m28m26m25m23m23m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥51.4m¥95.8m−¥106.8m−¥6.7m¥869.2m−¥281.0m−¥21.5m−¥403.7m−¥32.8m−¥802.8m
Capital spending−¥102.0m−¥52.6m−¥24.0m−¥155.3m−¥2.25bn−¥1.81bn−¥230.3m−¥96.4m−¥114.8m−¥270.1m
Free cash flow−¥50.6m¥43.2m−¥130.8m−¥162.0m−¥1.38bn−¥2.09bn−¥251.8m−¥500.1m−¥147.7m−¥1.07bn
Dividends paid————−¥138.3m−¥138.3m−¥191.5m−¥50,000−¥69,000−¥194,000

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥1.44bn¥1.24bn¥1.22bn¥1.32bn¥1.23bn¥1.26bn¥1.12bn¥1.08bn
Gross profit¥426.4m¥369.5m¥377.5m¥410.6m¥350.4m¥383.5m¥293.0m¥354.0m
Operating income¥67.0m¥49.6m¥28.9m¥55.8m−¥37.6m¥27.4m−¥64.0m−¥47.0m
Net income¥193.3m¥139.7m¥7.5m¥54.4m−¥66.9m−¥30.1m−¥77.0m−¥79.0m
Diluted earnings per share7.055.100.271.98-2.44-1.10-2.79-2.86
Total assets¥5.85bn¥5.57bn¥5.28bn¥5.16bn¥4.94bn¥5.71bn¥5.95bn¥6.02bn
Cash and short-term investments¥1.37bn¥942.7m¥1.01bn¥1.01bn¥1.04bn¥1.82bn¥1.72bn¥1.64bn
Debt¥1.03bn¥790.0m¥836.7m¥702.0m¥534.2m¥912.4m¥1.23bn¥1.02bn
Shareholders' equity¥4.09bn¥3.89bn¥3.85bn¥3.81bn¥3.76bn¥3.83bn¥3.97bn¥4.02bn

Financial ratios

Data as of 13 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin30.4%29.4%23.9%25.6%33.5%33.3%—
Operating margin3.9%-4.9%-26.9%-23.4%2.8%8.5%—
Net margin7.6%-5.4%-28.2%-25.1%0.6%8.6%—
Return on equity9.7%-6.7%-27.1%-25.4%0.7%12.1%—
Return on assets6.7%-5.1%-17.5%-13.6%0.4%6.9%—
Free cash flow yield2.5%2.4%-1.3%2.4%50.6%24.8%—
Revenue growth11.2%17.9%-24.6%-29.0%-20.1%83.5%—
Earnings growth-256.0%-77.4%-15.3%-3021.0%-94.3%-796.6%—
Current ratio2.79x2.94x2.35x2.93x3.15x2.41x—
Debt to equity0.25x0.14x0.33x0.74x0.62x0.56x—
Equity ratio69.9%76.2%64.8%53.5%57.1%56.9%—
Interest coverage11.99x-11.10x-33.92x-30.41x5.39x47.48x—
R&D as a share of sales—2.7%5.4%7.1%5.2%5.9%10.3%
Buybacks as a share of market value0.2%0.6%0.0%0.0%0.0%-4.8%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-0.4%-10.9%1.6%
Operating income—-25.8%—
Net income—-13.1%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin29.9%27.5%30.2%31.4%
Operating margin0.8%-10.4%-2.5%-4.4%
Net margin1.4%-12.0%-4.1%-7.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings13.4-20.2-5.7-5.4259.016.8-221.572.7-13.5-27.5
Price to sales1.01.11.61.41.61.45.02.21.74.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Jun 2021.

FY2022FY2015FY2014FY2011
Paid in the year5.007.5011.507.50
  • 200-for-1 split · 26 Dec 2013
  • 2-for-1 split · 28 Jun 2010
  • 4-for-1 split · 25 Dec 2001

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.